Serenex's Series D Round

Serenex raised a round of funding on June 18, 2007.

Serenex is an integrated oncology-focused drug discovery and development company. The company aims to improve the lives of cancer patients by developing therapeutic and supportive care products. Seren…

Articles about Serenex's Series D Round: